Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer
Drug Targets and Therapeutics · 30.09.2023 · 2 (2) · 111-123
DOI: 10.58502/dtt.23.0021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, erschienen am 30.09.2023. Verfasst von Steffanus Pranoto Hallis und 4 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
Zitieren
APA
Hallis, S. P., Go, B. J., Yoo, J. M., Cho, G. H., & Kwak, M. (2023). Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer. Drug Targets and Therapeutics, 2(2), 111-123. https://doi.org/10.58502/dtt.23.0021
Vancouver
Hallis SP, Go BJ, Yoo JM, Cho GH, Kwak M. Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer. Drug Targets and Therapeutics. 2023;2(2):111-123. doi:10.58502/dtt.23.0021
BibTeX
@article{Hallis2023,
author = {Hallis, Steffanus Pranoto and Go, Beam Ju and Yoo, Jun Min and Cho, Geun Hee and Kwak, Mi-Kyoung},
title = {Toward a Better Understanding of NRF2/NFE2L2 and BCRP/ABCG2 in Therapy Resistance in Cancer},
journal = {Drug Targets and Therapeutics},
year = {2023},
volume = {2},
number = {2},
pages = {111--123},
doi = {10.58502/dtt.23.0021}
}
EUVIMED